U.S.-listed shares of BioNTech jumped more than 15% Monday morning after the German vaccine maker announced a collaboration with Bristol Myers Squibb.

As of Tuesday, Bristol no longer is a racetrack. "It’s not going to be good to have a 2-foot wall ... in the outfield for a ...

Getty Images. Bristol Myers Squibb stock (NYSE: BMY) currently trades at $59 per share, 6% below the level seen in March 2021, and it has room for growth, in our view.

CNBC's Angelica Peebles joins 'Fast Money' to report on Bristol Myers Squibb's stock rise following FDA approval of Cobenfy for treating schizophrenia in adults. New evidence unsealed of how Trump ...

This was the stock's third consecutive day of losses.

Fleshing this point out, Bristol's stock was up by a modest 2.52% from January 2020 until the start of fourth quarter of 2021, while the SPDR S&P Biotech ETF, a closely followed gauge of biopharma ...

What happened. Bristol Myers Squibb (BMY 1.22%) stock was down by a noteworthy 5.4% as of 1:32 p.m. ET Monday afternoon. Bristol's share price is in retreat mode today after the company announced ...

It's been an abysmal year for Bristol Myers Squibb (BMY-0.89%) and its shareholders. The company's shares are down by nearly 30% year to date. That starkly contrasts with the broader market, which ...

Bristol-Myers Squibb Company (NYSE: BMY) is breaking out and poised to trend higher, Ritholtz Wealth Management CEO Josh Brown said Thursday on CNBC's "Fast Money Halftime Report." ...

The stock's fall snapped a five-day winning streak.